Skip to main content
. 2006 Jun 29;61(10):880–885. doi: 10.1136/thx.2006.060319

graphic file with name tx60319.f3.jpg

Figure 3 Attenuation of CXCL10 induced HLMC migration with KCa3.1 blockade. Triarylmethane‐34 (TRAM‐34) attenuated CXCL‐10 induced HLMC migration in a dose dependent manner. The pharmacologically distinct KCa3.1 blocker charybdotoxin (ChTX) attenuated CXCL10 induced HLMC migration with similar efficacy to TRAM‐34. Data are mean (SE) values from six separate donors. *p<0.005; **p<0.001.